Indian medical platform Digi-Prex Raises $5.5m to serve chronic patients.

Most of their business is conducted via Whatsapp.


Norshafa Wati

23 Sep, 2019

Indian medical platform Digi-Prex Raises $5.5m to serve chronic patients. | BEAMSTART News

- From our Sponsors -

Many businesses have started to use Whatsapp as part of their business and marketing strategy, including this Indian startup — Digi-Prex.

The Indian startup has raised USD5.5 million in a seed funding round from investors including Khosla Ventures, Vedanta Capital, Y Combinator, Quiet Capital and SV Angel — one of the largest seed financing rounds for an Indian startup.

Digi-Prex platform.

Digi-Prex is a chronic disease management platform which assists in the care of patients with chronic diseases, whereby patients share their prescription with Digi-Prex through WhatsApp and the startup’s workers then deliver the medication to them on a recurring cycle.

The new investment will allow the startup to expand its business to 10 cities across the country including Delhi, Bombay, Chennai, Bangalore, Calcutta, Ahmedabad, Indore, Jaipur, and Cochin.

- From our Sponsors -

Latest Jobs

Founding Customer Success Manager

Glimpse

New York,

Full Time

USD 140000 — USD 200000 yearly

Frontend Engineer (Contract)

Beam

Contract

USD 21 — USD 55 yearly

Customer Support Lead

Rally UXR

Full Time

USD 80000 — USD 130000 yearly

Dieter Rams

Entangl

California,

Full Time

USD 120000 — USD 150000 yearly

Founding Solutions/Sales Engineer

Agave

California,

Full Time

USD 120000 — USD 185000 yearly

Senior Full Stack Engineer

Bree

British Columbia,

Full Time

USD 100 — USD 160 yearly

Staff Data Scientist

Courtyard.io

Pennsylvania,

Full Time

USD 100000 — USD 200000 yearly

Software Engineer

Cobblestone

New York,

Full Time

USD 130 — USD 200000 yearly

BEAMSTART is a hub for everything Startups, Entrepreneurship, and Innovation. Connect with a global community of people, and stay updated with the latest startup jobs, news, and discussions.

 
© 2016 - 2025 BEAMSTART. All Rights Reserved (Legal).